Connect Biopharma Holdings Ltd. (CNTB)
0.6282
-0.04
(-5.56%)
USD |
NASDAQ |
Nov 19, 16:00
0.6201
-0.01
(-1.29%)
Pre-Market: 20:00
Connect Biopharma Holdings Net Income (Quarterly) : -16.15M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -16.15M |
| June 30, 2026 | -17.28M |
| March 31, 2026 | -19.40M |
| December 31, 2025 | -15.11M |
| Date | Value |
|---|---|
| September 30, 2025 | -17.20M |
| June 30, 2025 | -12.90M |
| March 31, 2025 | -10.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 7.824M |
| Vaxcyte, Inc. | -297.06M |
| Foghorn Therapeutics, Inc. | 58.15M |
| Caribou Biosciences, Inc. | -26.61M |
| Oncolytics Biotech, Inc. | -9.705M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.736M |
| Total Expenses (Quarterly) | 16.89M |
| EPS Diluted (Quarterly) | -0.2565 |
| Enterprise Value | 19.22M |
| Profit Margin (Quarterly) | -2.19K% |
| Earnings Yield | -182.1% |
| Normalized Earnings Yield | -182.08 |